Term ends Mar 11, 2035
Statutory term ends Oct 24, 2027
Base term plus 2695 days of PTA
Today
20y-from-earliest-nonprovisional
Expires Mar 2035
2007
2035
Clock starts
Oct 24, 2007
Oct 24, 2007
Granted
Jul 19, 2016
Jul 19, 2016
Term ends
Mar 11, 2035
Mar 11, 2035
base term
patent term adjustment
fee events
Computed Sep 1, 2026 · countdowns run from that date · how we know
2,695
Days of PTA
34
Applications in this family
This patent's term runs 2695 days past the statutory base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How this date was computed
Every step shows its rule, its input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20y-from-earliest-nonprovisional | Clock starts Oct 24, 2007 | Oct 24, 2027 | High |
| Continuity chain | Every parent in the chain resolved | no change | High |
| Patent term adjustment | +2695 days, USPTO PTA record | Mar 11, 2035 | High |
| Terminal disclaimer cap | None on record | no cap applied | High |
| Patent term extension | None on file | no change | High |
| Fee events | 2 of 3 maintenance fees paid | in-force | High |
| Computed term end | The steps above, in order | Mar 11, 2035 | High |
The computation, verbatim
base=20y-from-earliest-nonprovisional: 2007-10-24+20y | =2027-10-24 | PTA+2695d=2035-03-11 | PTE:none | TD:none | paid 4yr@2020-01-20,8yr@2024-01-19 | status=in-force@2035-03-11
This family
| Application 60/857,440 | pending | not computed |
| Application 60/910,625 | pending | not computed |
| Application 60/910,618 | pending | not computed |
| Application 11/923,357 | abandoned | not computed |
| US 9,392,935 | this patent | Mar 2035 |
| US 8,025,656 | in-force | Dec 2027 |
| Application PCT/US2007/083833 | pending | not computed |
| Application PCT/US2007/083982 | pending | not computed |
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 29, 2008 reel/frame not recorded | Adams, Ronald D.; Gruber, William H.; Drew, Douglas R.; Foshee, David L.; Mosler, Theodore J. | Interlace Medical, Inc. | Assignment of Assignor's Interest |
| Feb 18, 2011 reel/frame not recorded | Interlace Medical, Inc. | Hologic, Inc. | Assignment of Assignor's Interest |
| Aug 1, 2012 reel/frame not recorded | Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Gen-Probe Incorporated; Hologic, Inc.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc. | Goldman Sachs Bank USA | Security Agreement |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Hologic, Inc. | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Biolucent, LLC | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Cytyc Corporation | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Cytyc Surgical Products, Limited Partnership | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Suros Surgical Systems, Inc. | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Third Wave Technologies, Inc. | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Gen-Probe Incorporated | Security Interest Release Reel/Frame 028810/0745 |
| Aug 7, 2015 Reel 36307, frame 199 | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc. | Bank of America, N.A., as Collateral Agent | Security Agreement |
| Aug 7, 2015 reel/frame not recorded | Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Hologic, Inc.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc. | Bank of America, N.A., as Collateral Agent | Security Agreement |
Free plan: 3 watched companies. Pro: unlimited.
alerts on grants, lapses, transfers
Is this your company? Verify this record
What's changing
Mar 2035
Term ends. Maintenance fees still fall due before then
Note
The 2695 days of PTA are read from the USPTO record, not recalculated by us
Citations
17
later US patents cite this one
Patents granted this recently have not had time to be cited, so we show the count and do not rank on it.
How we rank
Every date shows its work: base rule, PTA, PTE, disclaimer caps, fee overlay, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.